Literature DB >> 24989896

First-time prescriptions of biological disease-modifying antirheumatic drugs in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis 2002-2011: data from the NOR-DMARD register.

Elisabeth Lie1, Karen M Fagerli1, Knut Mikkelsen2, Erik Rødevand3, Ase Lexberg4, Synøve Kalstad5, Till Uhlig1, Tore K Kvien1.   

Abstract

Entities:  

Keywords:  Ankylosing Spondylitis; DMARDs (biologic); Psoriatic Arthritis; Rheumatoid Arthritis; Spondyloarthritis

Mesh：

Substances：

Year:  2014        PMID： 24989896     DOI： 10.1136/annrheumdis-2014-205490

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

Review 1.  Biologics registers in RA: methodological aspects, current role and future applications.

Authors:  Elena Nikiphorou; Maya H Buch; Kimme L Hyrich
Journal:  Nat Rev Rheumatol       Date:  2017-06-01       Impact factor: 20.543

2.  Real Life Experience of First Course of Anti-TNF Treatment in Ankylosing Spondylitis Patients in Brazil.

Authors:  Marina Amaral de Ávila de Machado; Alessandra Maciel Almeida; Adriana Maria Kakehasi; Francisco de Assis Acurcio
Journal:  Rheumatol Ther       Date:  2016-01-29

3.  A European chart review study on early rheumatoid arthritis treatment patterns, clinical outcomes, and healthcare utilization.

Authors:  Paul Emery; Caitlyn Solem; Istvan Majer; Joseph C Cappelleri; Miriam Tarallo
Journal:  Rheumatol Int       Date:  2015-07-12       Impact factor: 2.631

Review 4.  A paradigm shift in studies based on rheumatoid arthritis clinical registries.

Authors:  Soo-Kyung Cho; Yoon-Kyoung Sung
Journal:  Korean J Intern Med       Date:  2019-02-18       Impact factor: 2.884

5.  No deterioration in health-related quality of life in patients with axial spondyloarthritis followed for 5 years in ordinary outpatient clinics in the biological treatment era.

Authors:  Gudrun Rohde; Kari Hansen Berg; Are Hugo Pripp; Anne Prøven; Glenn Haugeberg
Journal:  Qual Life Res       Date:  2019-09-26       Impact factor: 4.147

6.  Real-world evidence of biologic treatments in psoriatic arthritis in Italy: results of the CHRONOS (EffeCtiveness of biologic treatments for psoriatic artHRitis in Italy: an ObservatioNal lOngitudinal Study of real-life clinical practice) observational longitudinal study.

Authors:  Delia Colombo; Micol Frassi; Giusy Pagano Mariano; Enrico Fusaro; Claudia Lomater; Patrizia Del Medico; Florenzo Iannone; Rosario Foti; Massimiliano Limonta; Antonio Marchesoni; Bernd Raffeiner; Ombretta Viapiana; Walter Grassi; Rosa Daniela Grembiale; Giuliana Guggino; Antonino Mazzone; Enrico Tirri; Roberto Perricone; Pier Carlo Sarzi Puttini; Salvatore De Vita; Fabrizio Conti; Alessandra Ori; Lucia Simoni; Martina Fiocchi; Roberto Orsenigo; Emanuela Zagni
Journal:  BMC Rheumatol       Date:  2022-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.